BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 17088896)

  • 1. Hsp90 inhibition results in autophagy-mediated proteasome-independent degradation of IkappaB kinase (IKK).
    Qing G; Yan P; Xiao G
    Cell Res; 2006 Nov; 16(11):895-901. PubMed ID: 17088896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective degradation of the IkappaB kinase (IKK) by autophagy.
    Li D
    Cell Res; 2006 Nov; 16(11):855-6. PubMed ID: 17109011
    [No Abstract]   [Full Text] [Related]  

  • 3. Hsp90 regulates processing of NF-kappa B2 p100 involving protection of NF-kappa B-inducing kinase (NIK) from autophagy-mediated degradation.
    Qing G; Yan P; Qu Z; Liu H; Xiao G
    Cell Res; 2007 Jun; 17(6):520-30. PubMed ID: 17563756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geldanamycin inhibits tyrosine phosphorylation-dependent NF-kappaB activation.
    Crèvecoeur J; Merville MP; Piette J; Gloire G
    Biochem Pharmacol; 2008 Jun; 75(11):2183-91. PubMed ID: 18455150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained activation of protein kinase C downregulates nuclear factor-kappaB signaling by dissociation of IKK-gamma and Hsp90 complex in human colonic epithelial cells.
    Park KA; Byun HS; Won M; Yang KJ; Shin S; Piao L; Kim JM; Yoon WH; Junn E; Park J; Seok JH; Hur GM
    Carcinogenesis; 2007 Jan; 28(1):71-80. PubMed ID: 16774932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theileria-induced constitutive IKK activation is independent of functional Hsp90.
    Hermann P; Dobbelaere DA
    FEBS Lett; 2006 Sep; 580(21):5023-8. PubMed ID: 16938294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
    Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct regulation of insulin receptor substrate-1 and -2 by 90-kDa heat-shock protein in adrenal chromaffin cells.
    Yoshikawa N; Nemoto T; Satoh S; Maruta T; Yanagita T; Chosa E; Wada A
    Neurochem Int; 2010 Jan; 56(1):42-50. PubMed ID: 19737590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteome-wide changes induced by the Hsp90 inhibitor, geldanamycin in anaplastic large cell lymphoma cells.
    Schumacher JA; Crockett DK; Elenitoba-Johnson KS; Lim MS
    Proteomics; 2007 Aug; 7(15):2603-16. PubMed ID: 17610208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat shock protein 90 regulates the stability of MEKK3 in HEK293 cells.
    Fang S; Fu J; Yuan X; Han C; Shi L; Xin Y; Luo L; Yin Z
    Cell Immunol; 2009; 259(1):49-55. PubMed ID: 19560753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an HSP90 modulated multi-step process for ERBB2 degradation in breast cancer cells.
    Castagnola P; Bellese G; Birocchi F; Gagliani MC; Tacchetti C; Cortese K
    Oncotarget; 2016 Dec; 7(51):85411-85429. PubMed ID: 27863425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP2E1 degradation by in vitro reconstituted systems: role of the molecular chaperone hsp90.
    Goasduff T; Cederbaum AI
    Arch Biochem Biophys; 2000 Jul; 379(2):321-30. PubMed ID: 10898951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indirect participation of Hsp90 in the regulation of the cyclin E turnover.
    Bedin M; Catelli MG; Cabanié L; Gaben AM; Mester J
    Biochem Pharmacol; 2009 Jan; 77(2):151-8. PubMed ID: 18977205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement of Hsp90 activity for IkappaB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-kappaB activation.
    Broemer M; Krappmann D; Scheidereit C
    Oncogene; 2004 Jul; 23(31):5378-86. PubMed ID: 15077173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate immunity meets with cellular stress at the IKK complex: regulation of the IKK complex by HSP70 and HSP90.
    Salminen A; Paimela T; Suuronen T; Kaarniranta K
    Immunol Lett; 2008 Apr; 117(1):9-15. PubMed ID: 18282612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-proliferative activity of heat shock protein (Hsp) 90 inhibitors via beta-catenin/TCF7L2 pathway in adult T cell leukemia cells.
    Kurashina R; Ohyashiki JH; Kobayashi C; Hamamura R; Zhang Y; Hirano T; Ohyashiki K
    Cancer Lett; 2009 Oct; 284(1):62-70. PubMed ID: 19464103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geldanamycin-induced PCNA degradation in isolated Hsp90 complex from cancer cells.
    Wang X; Heuvelman DM; Carroll JA; Dufield DR; Masferrer JL
    Cancer Invest; 2010 Jul; 28(6):635-41. PubMed ID: 20394503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock protein 90 inhibitor induces apoptosis and attenuates activation of hepatic stellate cells.
    Myung SJ; Yoon JH; Kim BH; Lee JH; Jung EU; Lee HS
    J Pharmacol Exp Ther; 2009 Jul; 330(1):276-82. PubMed ID: 19329756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy: links with the proteasome.
    Lamark T; Johansen T
    Curr Opin Cell Biol; 2010 Apr; 22(2):192-8. PubMed ID: 19962293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pim-1 kinase stability is regulated by heat shock proteins and the ubiquitin-proteasome pathway.
    Shay KP; Wang Z; Xing PX; McKenzie IF; Magnuson NS
    Mol Cancer Res; 2005 Mar; 3(3):170-81. PubMed ID: 15798097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.